Advancing the Future of Medicine
Remarkable advancements in cell and gene therapy (CGT) – once considered science fiction – have become a clinical reality, providing life-changing care for people with serious diseases. With dozens of CGTs on the market and hundreds more in late-stage development, the potential to impact millions of patients is within reach.
Our 2024 Cell and Gene Therapy Report reviews where CGT stands today and its future trajectory, while exploring pain points and barriers to broader adoption and access. The report shares perspectives from experts across the industry, data from a survey of 124 oncologists about their use of CGT products, and a first-of-its-kind map illustrating the “CGT deserts” across the US.
Most importantly, it outlines real solutions to the challenges facing CGTs and examines how the healthcare industry can work together to overcome these barriers to enable more advanced care for patients.
Frequently asked questions
Map of CGT access: Qualified treatment centers across the US
